Upcoming Reports [full schedule to be confirmed]
Schedule of Publications 2023
2023
Nov
Launch of 2023-2024 survey
New Survey 2023
Oct
Neurological Edition [with Multiple Sclerosis]
Corporate Reputation of Pharma 2022
Environmental, Social & Governance Report
New Survey 2023
Sep
Arthritis Edition
Corporate Reputation of Pharma 2022
Mental Health Edition
Corporate Reputation of Pharma 2022
Published
Spain Edition
Corporate Reputation of Pharma 2022
Published
Aug
Ukraine Report
New Survey 2023
Published
Rare Diseases Edition [with Bleeding Disorders]
Corporate Reputation of Pharma 2022
Published
Australia, New Zealand, China and Japan Edition
Corporate Reputation of Pharma 2022
Published
Jul
Respiratory Edition
Corporate Reputation of Pharma 2022
Published
France Edition
Corporate Reputation of Pharma 2022
Published
Jun
Italy Edition
Corporate Reputation of Pharma 2022
Published
Germany Edition
Corporate Reputation of Pharma 2022
Published
Cancer Edition
Corporate Reputation of Pharma 2022
Published
May
Canada Edition
Corporate Reputation of Pharma 2022
Published
UK Edition
Corporate Reputation of Pharma 2022
Published
USA Edition
Corporate Reputation of Pharma 2022
Published
Apr
Global Edition
Corporate Reputation of Pharma 2022
Published
2022
Nov
Mental Health Edition
Corporate Reputation of Pharma 2021
Published
Neurological Edition
Corporate Reputation of Pharma 2021
Published
Oct
Autoimmune Edition
Corporate Reputation of Pharma 2021
Published
Respiratory Edition
Corporate Reputation of Pharma 2021
Published
Sep
Rare Diseases Edition (with Bleeding Disorders subanalyses)
Corporate Reputation of Pharma 2021
Published
Italy Edition
Corporate Reputation of Pharma 2021
Published
Spain Edition
Corporate Reputation of Pharma 2021
Published
Aug
Asia Edition
Corporate Reputation of Pharma 2021
Published
Germany Edition
Corporate Reputation of Pharma 2021
Published
Jul
UK Edition
Corporate Reputation of Pharma 2021
Published
France Edition
Corporate Reputation of Pharma 2021
Published
Jun
ESG report
Corporate Reputation of Pharma 2021
Published
Canada Edition
Corporate Reputation of Pharma 2021
Published
HIV/AIDS Edition
Corporate Reputation of Pharma 2021
Published
May
MAIN Cancer [including subanalyses]
Cancer Edition, Corporate Reputation of Pharma 2021
Published
USA Edition
Corporate Reputation of Pharma 2021
Published
Apr
Global Edition
Corporate Reputation of Pharma 2021
Published